肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

肺微环境:肿瘤生长和转移的重要调节因子

The lung microenvironment: an important regulator of tumour growth and metastasis

原文发布日期:2018-12-10

DOI: 10.1038/s41568-018-0081-9

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

肺微环境:肿瘤生长和转移的重要调节因子

The lung microenvironment: an important regulator of tumour growth and metastasis

原文发布日期:2018-12-10

DOI: 10.1038/s41568-018-0081-9

类型: Review Article

开放获取: 否

 

英文摘要:

Lung cancer is a major global health problem, as it is the leading cause of cancer-related deaths worldwide. Major advances in the identification of key mutational alterations have led to the development of molecularly targeted therapies, whose efficacy has been limited by emergence of resistance mechanisms. US Food and Drug Administration (FDA)-approved therapies targeting angiogenesis and more recently immune checkpoints have reinvigorated enthusiasm in elucidating the prognostic and pathophysiological roles of the tumour microenvironment in lung cancer. In this Review, we highlight recent advances and emerging concepts for how the tumour-reprogrammed lung microenvironment promotes both primary lung tumours and lung metastasis from extrapulmonary neoplasms by contributing to inflammation, angiogenesis, immune modulation and response to therapies. We also discuss the potential of understanding tumour microenvironmental processes to identify biomarkers of clinical utility and to develop novel targeted therapies against lung cancer.

 

摘要翻译: 

肺癌是全球性的重大健康问题,在世界范围内是癌症相关死亡的主要原因。关键突变改变识别方面的重大进展推动了分子靶向疗法的开发,但其疗效受限于耐药机制的出现。美国食品药品监督管理局批准的血管靶向疗法及近期兴起的免疫检查点疗法,重新激发了人们对肿瘤微环境在肺癌中预后及病理生理作用的研究热情。本综述重点探讨肿瘤重编程的肺微环境如何通过影响炎症、血管生成、免疫调节及治疗反应,促进原发性肺癌和肺外肿瘤肺转移的最新研究进展与新兴概念。我们还将讨论通过理解肿瘤微环境过程来识别临床可用生物标志物,并开发针对肺癌的新型靶向疗法的潜力。

 

原文链接:

The lung microenvironment: an important regulator of tumour growth and metastasis

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……